Poxviruses replicate in the cytoplasm of the cell and encode enzymes and factors needed for transcription of their genomes. Vaccinia virus, therefore, provides a unique system for combining biochemical and genetic approaches for investigating mechanisms of gene regulation and mRNA biosynthesis. Studies with vaccinia virus indicated that the genes are divided into three temporal classes - early, intermediate and late - that are regulated in a cascade fashion. The sites of interaction of the 82- and 70-kDa subunits of the early transcription factor (VETF) with the promoter were determined using DNA that was modified by the incorporation of aryl azide residues. We found that the 82-kDa subunit was cross-linked primarily with the core region of the promoter while the 70-kDa subunit interacted with the downstream region. Mutations in core region resulted in the loss of binding specificity. To investigate additional roles of VETF, we constructed a conditionally lethal recombinant vaccinia virus in which the D6R gene, encoding the 70-kDa subunit of VETF, is under stringent E. coli lac operator control. Electron microscopy revealed that immature virus particles and masses of electron dense material accumulated in the absence of inducer. We considered that VETF has a direct role in virion morphogenesis in addition to serving as an early transcription factor. The 26-kDa protein encoded by the vaccinia virus A2L open reading frame was shown to be required for in vitro transcription of a template with a late promoter and named late transcription factor 3 (VLTF-3). A fourth late transcription factor (VLTF-4) was purified to homogeneity from vaccinia virus infected HeLa cells and shown to be a product of the H5R open reading frame. Both VLTF-3 and VLTF-4 were expressed with a baculovirus vector and shown to be active in transcription assays.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Intramural Research (Z01)
Project #
1Z01AI000307-15
Application #
2566740
Study Section
Special Emphasis Panel (LVD)
Project Start
Project End
Budget Start
Budget End
Support Year
15
Fiscal Year
1996
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
De Silva, Frank S; Paran, Nir; Moss, Bernard (2009) Products and substrate/template usage of vaccinia virus DNA primase. Virology 383:136-41
Hebben, Matthias; Brants, Jan; Birck, Catherine et al. (2007) High level protein expression in mammalian cells using a safe viral vector: modified vaccinia virus Ankara. Protein Expr Purif 56:269-78
Parrish, Susan; Resch, Wolfgang; Moss, Bernard (2007) Vaccinia virus D10 protein has mRNA decapping activity, providing a mechanism for control of host and viral gene expression. Proc Natl Acad Sci U S A 104:2139-44
Katsafanas, George C; Moss, Bernard (2007) Colocalization of transcription and translation within cytoplasmic poxvirus factories coordinates viral expression and subjugates host functions. Cell Host Microbe 2:221-8
Parrish, Susan; Moss, Bernard (2007) Characterization of a second vaccinia virus mRNA-decapping enzyme conserved in poxviruses. J Virol 81:12973-8
Garcia, Alonzo D; Otero, Joel; Lebowitz, Jacob et al. (2006) Quaternary structure and cleavage specificity of a poxvirus holliday junction resolvase. J Biol Chem 281:11618-26
Parrish, Susan; Moss, Bernard (2006) Characterization of a vaccinia virus mutant with a deletion of the D10R gene encoding a putative negative regulator of gene expression. J Virol 80:553-61
Domi, Arban; Moss, Bernard (2005) Engineering of a vaccinia virus bacterial artificial chromosome in Escherichia coli by bacteriophage lambda-based recombination. Nat Methods 2:95-7
De Silva, Frank S; Moss, Bernard (2005) Origin-independent plasmid replication occurs in vaccinia virus cytoplasmic factories and requires all five known poxvirus replication factors. Virol J 2:23
Katsafanas, George C; Moss, Bernard (2004) Vaccinia virus intermediate stage transcription is complemented by Ras-GTPase-activating protein SH3 domain-binding protein (G3BP) and cytoplasmic activation/proliferation-associated protein (p137) individually or as a heterodimer. J Biol Chem 279:52210-7

Showing the most recent 10 out of 25 publications